Loading…
Reported covered position: Services
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590. Seeking TRICARE coverage for laboratory-developed tests.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2010 · first_quarter · Q1
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590. Seeking TRICARE coverage for laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590. Seeking TRICARE coverage for laboratory-developed tests.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
American Middle Class Tax (AMT) Relief Act of 2007
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590.
American Middle Class Tax (AMT) Relief Act of 2007
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699, S. 1220 and H.R. 3590. Seeking TRICARE coverage for laboratory-developed tests.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699.
Patient Access to Critical Lab Tests Act
Client: GENOMIC HEALTH INC · Firm: MCDERMOTT WILL & SCHULTE LLP
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699.
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2009 · first_quarter · Q1
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests, seeking to advance H.R. 1699.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENOMIC HEALTH INC via MCDERMOTT WILL & SCHULTE LLP
2008 · fourth_quarter · Q4
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
FDA regulation of laboratory-developed tests. Medicare reimbursement for laboratory-developed tests.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INTERMOUNTAIN HEALTH via MCDERMOTT WILL & SCHULTE LLP
2008 · fourth_quarter · Q4
Seeking clarification with respect to satellite hospital rules
Filing targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE